| 000 | 01530 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250513104332.0 | ||
| 264 | 0 | _c19970204 | |
| 008 | 199702s 0 0 eng d | ||
| 022 | _a0931-0509 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSunder-Plassmann, G | |
| 245 | 0 | 0 |
_aSafety of intravenous injection of iron saccharate in haemodialysis patients. _h[electronic resource] |
| 260 |
_bNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association _cSep 1996 |
||
| 300 |
_a1797-802 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aDrug Tolerance |
| 650 | 0 | 4 |
_aErythropoietin _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFerric Compounds _xadministration & dosage |
| 650 | 0 | 4 | _aFerric Oxide, Saccharated |
| 650 | 0 | 4 |
_aFerritins _xblood |
| 650 | 0 | 4 | _aGlucaric Acid |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 |
_aIron _xblood |
| 650 | 0 | 4 |
_aKidney Failure, Chronic _xdrug therapy |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRecombinant Proteins |
| 650 | 0 | 4 | _aRenal Dialysis |
| 650 | 0 | 4 |
_aTransferrin _xmetabolism |
| 700 | 1 | _aHörl, W H | |
| 773 | 0 |
_tNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association _gvol. 11 _gno. 9 _gp. 1797-802 |
|
| 999 |
_c8911088 _d8911088 |
||